Molecular Insight Pharmaceuticals, Inc.

Quick facts

Phase 2 pipeline

• Drug: 99mTc-MIP-1404
• Ultratrace Iobenguane I131
• UltratraceTM Iobenguane I 131 Imaging
• UltratraceTM Iobenguane I 131 Therapy

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Molecular Insight Pharmaceuticals, Inc. portfolio CI brief
• Molecular Insight Pharmaceuticals, Inc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies